ANXA2 and plasma cell myeloma: Both AnxA2kd and AnxA5kd cells have decreased proliferative capacity compared to Si cells (Figures 2A–C), and suppression of AnxA2 by shRNA similarly decreases proliferation of adenocarcinoma [26], breast cancer [27], and multiple myeloma [28] cells.